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Abstract 
Background  Key performance indices such as door-to-balloon times have long been recognized as quality metrics in reducing time to 
care for patients with acute coronary syndromes (ACS). In the situation where patients do not present to a facility capable of 24/7 percutane-
ous coronary interventions (PCI) delays in time to therapy can exceed the recommendation of 90 min or less. This study aimed to evaluate 
the impact of transfers on performance indices for patients diagnosed with ST-segment elevation myocardial infarction (STEMI). 
Methods  Over a seven month collection period, all patients presenting with symptoms suggestive of ACS and admitted for PCI were stud-
ied. Patients were divided into dichotomous groups of direct presentations or transfers from a secondary non-PCI capable hospital with key 
times recorded, including symptom-onset, first hospital and PCI-capable hospital arrival and balloon inflation times to evaluate time of 
treatment for STEMI patients. Results  Of the 87 patients diagnosed with STEMI, transferred patients experienced statistically significant 
delays in symptom-onset to the PCI-capable hospital (PCI-H) arrival (215 vs. 95 min, P < 0.001), symptom-onset to balloon inflation (225 vs. 
160 min, P = 0.009) and first hospital arrival to balloon inflation times (106 vs. 56 min, P < 0.001). Only 28% (n = 9) of transferred patients 
underwent balloon inflation within 90 min from first hospital arrival, while 60% (n = 19) did within 120 min, although all received balloon 
inflation within 90 min from arrival at the PCI-H. After controlling for confounding factors of socio-economic status, presentation date/ time 
and diagnostic category, transferred patients experienced an average 162% longer delays from symptom-onset to PCI-H door arrival, and 
98% longer delays in symptom-onset to balloon inflation; compared to patients who present directly to the PCI-H. No statistically significant 
differences were noted between transferred and direct patients when measured from PCI-H door-to-balloon times. Conclusions  This study 
shows that transferred patients experience a greater overall system delay, compared to patients who present directly for PCI, significantly 
increasing their time to treatment and therefore infarct times. Despite the majority of transfers experiencing pre-hospital activation, their 
treatment hospital arrival to balloon times are no less than direct presenters after controlling for confounding factors, further compounding 
the overall delay to therapy. 
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1  Introduction 
Cardiovascular disease is recognised as a leading cause 
of death and disability across the globe with troubling dis-
parities noted between metropolitan and rural communi-
ties.[1–3] Australia has identified this as an area of priority 
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under the National Health Priority Area initiative.[4] Spe-
cifically, acute coronary syndrome (ACS) which collec-
tively spans presentations of acute myocardial infarction, in-
cluding ST-segment elevation myocardial infarction (STEMI), 
Insert (NSTEMI) and unstable angina[5,6], was the cause of 
death for 6.1% Western Australians in 2015.[7] Presentations 
of STEMI are considered medical emergencies and positive 
outcomes including lower mortality rates are highly corre-
lated with timely reperfusion of the culprit vessel.[8–11] Given 
this time crucial nature, there has been considerable focus 
surrounding the reduction of measurable performance indi-
ces for time to therapy, namely door-to-electrocardiogram 
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(DTE), door-to-needle (DTN) and door- to-balloon (DTB) 
times for ACS patients; and more recently time from first 
medical contact to balloon times (FMC-B). Reduction in 
time to therapy is associated with improved outcomes and 
as such several international professional organisations have 
reached a consensus, calling for DTE times within 10 min 
for all presentations and DTB times of 90 min or less for 
patients who present direct to a hospital equipped with a 
cardiac catheterisation laboratory (CCL) for percutaneous 
coronary interventions (PCI).[8,9,12,13] Those patients who 
require transfers for PCI should have early activation of the 
CCL to reduce avoidable delays.[13] The 2016 Australian 
Clinical Guidelines for the Management of Acute Coronary 
Syndromes recommends primary PCI as the preferred 
reperfusion strategy for those patients diagnosed with 
STEMI, if it can be performed within 90 min of first medi-
cal contact (FMC); otherwise proceed to thrombolysis in the 
absence of contraindications.[14] Prior to the 2016 update, 
DTB times within 90 min were the key performance objec-
tive in Australia.[13] 
Timely transfer to PCI capable hospitals has been shown 
to reduce rates of death, re-infarction and stroke compared 
to on-site fibrinolysis[14,15] and strategies have been intro-
duced to reduce avoidable delays namely emergency de-
partment activation;[16,17] pre-hospital activation;[17] 30 min 
mobilisation of on call staff;[16,17] and ambulance based 
electrocardiogram (ECG) results transmission.[18,19] 
The aim of this study was to analyse the impact of in-
ter-hospital transfers within the Perth Metropolitan region 
on overall time-to-treatment when a patient needs to be 
transferred from a non-PCI capable metropolitan hospital to 
a facility that can offer round-the-clock PCI. 
2  Methods 
2.1  Study population 
Data of all Western Australians resident patients aged 18 
years or older who presented to a single Perth metropolitan 
teaching hospital, PCI-capable hospital (PCI-H), with 
round-the-clock CCL facilities with a diagnosis of STEMI 
between June 2013 and December 2013 were de-identified 
for analysis. Data for every admission to the PCI-H Cardio-
vascular Medicine Department are routinely collected as 
part of the department’s standard clinical management pro-
gram, as a single-centre cardiac registry. Human Research 
Ethical approval was obtained prior to data collection from 
the Human Research Ethics Committees of the Western 
Australian Department of Health, Curtin University, and the 
PCI-H. 
2.2  Characteristics of participants 
Socio-demographic data included a unique de-identified 
patient number, birth year, sex and postcode of residence; in 
addition to the clinical variables of admission date, dis-
charge date, time of symptom-onset, PCI-H arrival time, 
time of ECG, time of CCL activation, procedure start time, 
time of first balloon inflation, procedure end time, principal 
diagnosis, principal procedure (PCI, stent insertions, coro-
nary artery bypass graft), mode of arrival, length of stay in 
hospital and mode of discharge from the PCI-H. Addition-
ally for those patients who were transferred from another 
hospital, first hospital arrival time and first hospital depar-
ture time were also available. Time-to-event variables were 
calculated from the difference in the time recorded between 
the two key events of interest and span symptom-onset to 
first hospital arrival [STD (First)], symptom-onset to PCI-H 
arrival [STD (PCI-H)], symptom-onset to first balloon infla-
tion (STB), first hospital arrival to first balloon inflation 
[DTB (First)], PCI-H arrival-to-first balloon inflation [DTB 
(PCI-H)], first hospital length of stay (referral LOS) and 
inter-hospital transfers (IHTs), all measured in min. Phar-
macological treatments are not coded in the data and as such 
DTN times could not be assessed, and it is unknown if 
transferred patients received thrombolytic therapy prior to 
transfer. Times of ambulance arrival were not recorded 
within the dataset and as such FMC to balloon times could 
not be evaluated. 
2.3  Statistical analysis 
All analyses were performed using SPSS Statistics Ver-
sion 22 (IBM Corporation, Armonk, NY, USA). Statistical 
significance was assigned at the level of P < 0.05. Cate-
gorical data were reported as frequencies and percentages, 
while continuous variables were reported as mean or medi-
ans, with standard deviations and range. ‘Between-group’ 
analyses were completed using Mann-Whitney U Test and 
the Pearson Chi Squared test, respectively. Multivariable 
generalised linear modelling applying a Gamma distribution 
with a log link function were performed to evaluate key times 
and identify predictors impacting length of stay for STEMI 
patients: candidate variables were chosen as those likely to 
contribute to confounding given the observational nature of 
the study (sex, age, socio-economic status, method of arrival 
to the PCI-H, presentation date/time, pre-hospital ECG, pre- 
hospital activation and transfer status) and were included in 
final models after backwards stepwise selection using P > 
0.05 as the level of significance for variable inclusion. 
3  Results 
Table 1 presents 107 subjects who met inclusion criteria  
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Table 1.  Socio-demographic, clinical characteristics and outcomes for all patient diagnosed with STEMI by transfer status. 
 All (n = 107) Direct (n = 66)  Transfers (n = 41) 
 n* %** n* %**  n* %** 
Age, yrs 60 ± 11.7 60 ± 11.3  59 ± 12.3 
Sex        
Male 87 81.3 56 84.8  31 75.6 
Female 20 18.7 10 15.2  10 24.4 
SEIFA        
Highest disadvantage 7 6.6 5 7.6  2 5.0 
High disadvantage 8 7.5 3 4.5  5 12.5 
Moderate disadvantage 15 14.2 11 16.7  4 10.0 
Less disadvantage 16 15.1 11 16.7  5 12.5 
Least disadvantage 60 56.6 36 54.5  24 60.0 
Health service area        
North metropolitan 95 89.6 57 86.4  38 95.0 
South metropolitan 8 7.5 6 9.1  2 5.0 
Western Australia country 3 2.8 3 4.5  0 0.0 
Arrival mode        
Medical transport 90 86.5 52 78.8  38 100.0 
Private transport 14 13.5 14 21.2  - - 
Presentation date/time^        
Weekday, 8 am5 pm 40 40.0 26 44.1  14 34.1 
Weekday, after hours 33 33.0 19 32.2  14 34.1 
Weekend, 8 am5 pm 16 16.0 8 13.6  8 19.5 
Weekend, after hours 11 11.0 6 10.2  5 12.2 
Pre-hospital activation        
Yes 27 42.9 15 30.0  12 92.3 
No 36 57.1 35 70.0  1 7.7 
Pre-hospital ECG (without electronic transmission)        
Yes 27 30.0 23 42.6  4 11.1 
No 63 70.0 31 57.4  32 88.9 
Primary diagnosis        
STEMI 87 81.3 51 77.3  36 87.8 
NSTEMI 6 5.6 5 7.6  1 2.4 
Unstable angina 1 0.9 0 0.0  1 2.4 
Subsequent AMIǂ  10 9.3 8 12.1  2 4.9 
Other 3 2.8 2 3.0  1 2.4 
Principal procedure        
PCI 24 22.4 16 24.2  8 19.5 
PCI + Stent insertion 80 74.8 49 74.2  31 75.6 
Coronary artery bypass graft 1 0.9 0 0.0  1 2.4 
Other intervention, non-coronary 2 1.9 1 1.5  1 2.4 
Length of stay, days 3 (032) 3 (016)  3 (132) 
In-hospital mortality        
Discharged 101 94.4 62 93.9  39 95.1 
Deceased 6 5.6 4 6.1  2 4.9 
Data are presented as means ± SD or median (interquartile range). *Refer to due to missing data, 'n' may not sum to the total sample size of 107. **Refer to per-
centage of total reported cases for each characteristic within each group. ^Refer to first hospital of presentation. ǂRefer to within 28 days of original AMI. AMI: 
acute myocardial infarction; ECG: electrocardiogram; NSTEMI: non-ST-segment elevation myocardial infarction; PCI: percutaneous coronary interventions; 
SEIFA: socio-economic indexes for areas; STEMI: ST-segment elevation myocardial infarction. 
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with a mean age of 60 years, of which 85% were males 
predominantly from the North Metropolitan Health Service 
catchment area (90%). Medical transport was attributed to 
86% of those who presented directly to the PCI-H, while it 
is unknown how patients presented to the first non-PCI-H. 
All transfers were via ambulance. Pre-hospital activation 
occurred in 30% of direct presentations and 92% of trans-
fers, conversely pre-hospital ECGs were obtained in 43% of 
direct presentations but only in 11% of transfers prior to 
arriving at the first non-PCI capable hospital. Primary PCI 
was attempted in 97% of patients, of which 75% went on to 
have at least one stent inserted in the target vessel. Median 
length of stay was three days with an in-hospital mortality 
rate of 6% (n = 6). 
Analysis was limited to only those patients diagnosed as 
STEMI, as this categorises those in immediate need of PCI. 
As shown in Table 2, in the crude (unadjusted for potential 
confounders) analysis no statistically significant differences 
were noted in time between symptom-onset and first hospi-
tal arrival between direct and transfers. Transferred patients 
experienced statistically significant delays in STD (PCI-H) 
times (215 vs. 95 min, P < 0.001), STB times (224 vs. 160 
min, P = 0.009) and DTB (First) times (106 vs. 58 min, P < 
0.001). However, transferred patients DTB (PCI-H) times 
were statistically significantly shorter than direct presenters 
(34 vs. 58 min, P = 0.012). This trend continues in Table 3 
with 28% of transfers having experienced balloon inflation 
within 90 min of first hospital arrival; and 59% within 120 min, 
and yet all transfers met target when measured from DTB 
(PCI-H) times. 
Table 4 shows that after accounting for confounding by 
socio-economic status, presentation date/time, transfer status, 
pre-hospital activation, pre-hospital ECG, mode of transport 
to the PCI-H, age and sex, statistically significant differ-
ences were observed with transfers having on average 118% 
longer delays from symptom-onset to first hospital arrival. 
This difference was further exacerbated when comparisons 
were made between STD (PCI-H) times, with transferred  
Table 2.  Crude key times to treatment for all patients diagnosed with STEMI by transfer status. 
 All (n = 51) Direct (n = 42) Transfers (n = 9) P > Z* 
aSTD (First) 90 (56165) 95 (59148) 76 (41277) 0.711 
bSTD (PCI-H) 110 (72215) 95 (59148) 215 (146695) < 0.001 
cSTB 181 (135289) 160 (125250) 224.5 (166405) 0.009 
dDTB (First) 80 (53109) 57.5 (4481) 106.5 (89145) < 0.001 
eDTB (PCI-H) 54 (4177) 57.5 (4481) 34 (3056) 0.012 
fLOS (Referral hospital) 43 (3672) - 43 (3672) - 
gIHT travel time 25 (1735) - 25 (1735) - 
Data are presented as median (interquartile range). aRefer to symptom onset to first hospital door arrival. bRefer to symptom onset to PCI-H door arrival. cRefer 
to symptom onset to balloon inflation. dRefer to first hospital door arrival to balloon inflation. eRefer to PCI-H door arrival to balloon inflation. fRefer to referral 
hospital length of stay. gRefer to inter-hospital transfer travel time. *Refer to test between direct and inter-hospital transfer patients using Mann Whitney U. 
DTB: door-to-balloon; IHT: inter-hospital transfer; LOS: length of stay; PCI-H: percutaneous coronary interventions-capable hospital; STB: symptom onset to 
balloon inflation; STD: symptom onset to first hospital door arrival; STEMI: ST-segment elevation myocardial infarction. 
Table 3.  Crude numbers and percentages of patient door-to-balloon times for all STEMI* patients by transfer status. 
 All (n = 87)  Direct (n = 51)  Transfers (n = 36)  P > Z** 
aDTB (First)        
90 min or less 49 (62.8%)  40 (87.0%)  9 (28.1%)  < 0.001 
Greater than 90 min 29 (37.2%)  6 (13.0%)  23 (71.9%)   
bDTB (First)        
120 min or less 61 (78.2%)  42 (91.3%)  19 (59.4%)  0.001 
Greater than 120 min 17 (21.8%)  4 (8.7%)  13 (40.6%)   
cDTB (PCI-H)        
90 min or less 51 (89.5%)  40 (87.0%)  11 (100.0%)  0.205 
Greater than 90 min 6 (10.5%)  6 (13.0%)  0   
aRefer to first hospital door arrival to balloon inflation (90 min or less). bRefer to first hospital door arrival to balloon inflation (120 min or less). cRefer to PCI-H 
door arrival to balloon inflation. *Refer to patients with confirmed ST-elevation myocardial infarction on electrocardiogram. **Refer to test between direct and 
inter-hospital transfer patients using Chi Squared. DTB: door-to-balloon; PCI-H: percutaneous coronary interventions-capable hospital; STEMI: ST-segment 
elevation myocardial infarction. 
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Table 4.  Adjusted mean times to treatment and length of stay by transfers, pre-hospital ECG activation. 
 Generalised linear modelǂ   Estimated marginal means*** 
 95% CI  95% CI 95% CI 
 
Coef* 
Lower Upper 
P > Z** 
 
Mean 
Lower Upper 
Mean 
Lower Upper
Transfer status   
 Inter-hospital transfer is baseline  Direct presentation Inter-hospital transfer 
aSTD (First) 1.18 0.49 1.87 0.001  113 83 154 369 205 665 
bSTD (Tertiary) 1.62 1.05 2.19 < 0.001  110 85 143 555 340 906 
cSTB 0.98 0.58 1.39 < 0.001  167 141 198 447 307 652 
dDTB (First) 1.26 0.91 1.61 < 0.001  55 48 64 195 143 267 
eDTB (PCI-H) 0.19 0.17 0.55 0.308  55 48 63 67 49 91 
CCL activation   
 No activation is baseline  Pre-hospital activation No pre-hospital activation 
cSTB 0.34 0.01 0.68 0.045  230 184 289 324 239 441 
dDTB (First) 0.81 0.52 1.10 < 0.001  69 58 83 156 120 202 
eDTB (PCI-H) 0.74 0.49 1.00 < 0.001  39 32 46 81 69 95 
ECG   
 No ECG is baseline  Pre-hospital ECG No pre-hospital ECG 
cSTB 0.51 0.85 0.17 0.004  353 256 487 212 171 262 
dDTB (First) 0.15 0.13 0.42 0.286  97 75 125 112 95 133 
eDTB (PCI-H) 0.27 0.02 0.52 0.033  49 41 59 64 55 75 
Length of stay, days (For those 
with DTBs 90 min or less) 
 
 
 DTB > 90 min is baseline  DTB 90 min or less DTB greater than 90 min 
dDTB (First) 0.510 0.204 0.816 0.001  4 3 5 7 5 9 
eDTB (PCI-H) 0.593 0.137 1.048 0.011  4 4 5 8 5 13 
aRefer to symptom onset to first hospital door arrival. bRefer to symptom onset to PCI-H door arrival. cRefer to symptom onset to balloon inflation. dRefer to 
first hospital door arrival to balloon inflation. eRefer to PCI-H door arrival to balloon inflation. ǂRefer to models were adjusted for sex, age, socio-economic 
status, method of arrival to PCI-H, presentation date/time, pre-hospital ECG, pre-hospital activation and transfer status. *Refer to coefficient B (relative proportional 
change in the mean value of the outcome variable in those transferred compared with the mean value in the baseline group). **Refer to test between groups 
within transfer status, cardiac catheterisation laboratory activation and pre-hospital ECG; using Wald Chi Square. ***Refer to estimated marginal means adjust 
for the covariate by reporting the means of year for each level of the factor at the mean value of the covariate. DTB: door-to-balloon; ECG: electrocardiogram; 
PCI-H: percutaneous coronary interventions-capable hospital; STB: symptom onset to balloon inflation; STD: symptom onset to first hospital door arrival. 
 
patients facing delays on average 162% greater than their 
direct counterparts, with model predicted average delays of 
555 min (340–906 min) compared to 110 min (85–143 min) 
respectively. Transferred patients also experienced statisti-
cally significantly longer delays in STB times of 98% with 
model based predicted delays for direct patients at 167 min 
(141–198 min) rising to 447 min (307–652 min) for trans-
fers. First hospital DTB times are 1.26 times longer for 
transferred patients, with the model predicting average times 
of 195 min (143–267 min) compared to just 55 min (48–64 
min) for direct presentations. However, when measured 
from PCI-H arrival, no significant differences were ob-
served. 
Failure to have a pre-hospital activation notably in-
creased DTB (First) by 81% and DTB (PCI-H) by 74%, 
increasing the overall time to treatment burden with pre-
dicted average first hospital DTB times of 69 min for those 
with pre-hospital activation jumping to 156 min for those 
without. Pre-hospital ECG statistically significantly reduced 
DTB (PCI-H) by 27% with an estimated marginal means of 
49 min (41–59 min); increasing to 64 min (55–75 min) for 
those who did not have a pre-hospital ECG. Experiencing 
DTB times of 90 min or less measured from both the first 
hospital and the PCI-H were found to significantly reduce 
the estimated mean length of stay by 51% and 59%, from 
four days to seven days (5–9 days) and eight days (5–13 
days), respectively. 
4  Discussion 
Despite DTB times from first hospital of presentation 
resulting in significantly longer delays to treatment for 
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transferred patients, the majority of these patients experi-
ence pre-hospital activation and therefore fortunately have 
similar, if not improved, DTB (PCI-H) times compared to 
direct presentations. However, the inherent delay associated 
with initial presentation to a secondary hospital without 
CCL capabilities, requiring triage and diagnosis prior to 
transfer by road to a CCL hospital has important implica-
tions in the Western Australians setting with travel notably 
hindering time to treatment.[20] An Italian study[21] showed 
similar results with the overall time to treatment metric 
longer for inter hospital transfers; but those same patients 
showed a significantly shorter door to balloon delay when 
measured from the single centre, due to early mobilisation 
of the CLL team. Rezaee, et al.[18] broke down the different 
components of delay after emergency medical services ar-
rival and after accounting for 15 min as the median 
time-on-scene, a further 29–32 min for in-hospital assess-
ment and transfer from the ED to the CCL and consequent 
balloon inflation, found the maximum allowable transport 
time was 43–46 min. In the Greater Perth region, this figure 
may be challenging to achieve for outer metro patients, let 
alone their rural and remote counterparts due to the dis-
tances involved. Average travel times by road, from the 
most northern, southern and eastern tips of the Greater Perth 
region (Greater Capital City Statistical Areas) to Perth City 
central are 75 min.[22] Inter hospital transfers are a topic of 
debate worldwide with numerus initiatives addressing the 
need to reduce transfer related delays in the primary treat-
ment of ACS.[23] A 2012 study from Brazil, et al.[24] showed 
direct presentations were associated with decreased total 
ischemia time, improve myocardial reperfusion markers and 
a non-significant decrease in hospital mortality; despite an 
integrated system which allows for a 60 minute-time inter-
val for inter-hospital transfer. 
Pre-hospital ECGs have previously shown to reduce 
DTB times,[25] although this was not the case in our study 
when measured from first hospital DTB times, after control-
ling for the effects of transfers status and pre-hospital acti-
vation. However, PCI-H DTB times were impacted with 
27% shorter DTB times for patients who had a pre-hospital 
ECG (49 vs. 64 min, P = 0.033). Similarly to this study, it 
has previously been shown any in-hospital time saving 
benefits from the acquisition of pre-hospital ECGs were 
only fully realised with the addition of pre-hospital CCL 
activation.[18] 
No statistically significant differences were noted in so-
ciodemographic factors between direct and transfers for 
patient diagnosed as STEMI as per the International Classi-
fication of Disease.[26] Further, there were no statistically 
significant differences in the type of interventions per- 
formed. In lieu of more detailed data on severity of disease, 
these figures indicate transferred patients were no more or 
less critical than direct presentations. Taking into considera-
tion the overall longer delay to PCI therapy due to triage at 
the first hospital and time to transfer, in conjunction with 
pre-hospital activation, it would be reasonable to expect 
rapid DTB times once arriving at PCI-H to reduce overall 
delay burden. Unfortunately, this was not the case. Al-
though the transfers occurred within recommended guide-
lines for a single hospital, the overall system delay needs to 
be taken into consideration. 
The data does not include information on how patients 
arrived at secondary hospitals. Ambulance ECG was intro-
duced to Western Australia in during 2012/2013.[27] As-
suming all patients with ECG changes consistent with 
STEMI were taken directly to an available CCL, the pa-
tients who required transfer from a secondary hospital 
would have either self-presented to their nearest emergency 
department or were current inpatients. Given the transfer 
cohort would have known diagnoses of STEMI at the time 
of transfer, with 78% having pre PCI-H CCL activation, it 
would be reasonable to expect rapid PCI-H DTB times. 
Although within the guidelines for a single-centre, overall 
the burden of delay for these patients is well outside rec-
ommendations. 
The single most effective measure to reduce the time 
burden from first medical contact to definitive treatment has 
been shown to utilise ambulance-initiated ECG. Early iden-
tification of STEMI changes en route means patients can be 
rerouted directly to a PCI-equipped hospital, avoiding 
transfers after ED triage.[5,11,28,29] A secondary option is the 
development of a coordinated system to record the time of 
ED arrival or ambulance retrieval, which can then be ac-
cessed at the final receiving hospital to contribute to the 
time metrics analysis. Data including ECG changes, bio-
markers and any initial treatments are recorded. There is 
compelling evidence Cardiac Registries across the world 
drive continuous improvements in patient care and inform a 
medical centres ability to adhere to guideline recommenda-
tions. Such registries can be utilised in conjunction with 
linked administrative health data, to complete the long term 
picture of the burden of ACS and the short- and long-term 
outcomes.[28,30–32] 
If primary PCI cannot be performed within 90 min of 
first medical contact, thrombolysis should be considered as 
a primary reperfusion method. Every patient in this study 
was transferred for primary PCI as part of the inclusion cri-
teria. However, as this is a single centre study, treatments 
and therapies initiated at the first hospital of treatment were 
not coded within the data to identify those patients being 
transferred for rescue PCI. 
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It is beyond the scope of this study to analyze patient 
outcomes post-therapy. Clinical recommendations have 
been established for the known improvements in outcomes 
with reduced time to therapy and as such the focus of the 
paper is on the impact of transfers on time to therapy, rather 
than short- and long-term outcomes. However, it has previ-
ously been shown that for every 30-minute delay in PCI, 
there is a 1% increase in absolute risk of dying in hospi-
tal;[16,33] while another study showed an increase of 7.5% in 
risk of one-year mortality for every 30 min delay to treat-
ment.[34] In accordance with these findings, the median re-
ferral hospital length of stay of 52 min and mean transfer 
time of 25 min infers the addition of over an hour to the 
overall patient journey, ultimately increasing the absolute 
risk of in-hospital mortality by 2.0% with the one-year 
mortality risk at least 15% greater for transferred patients. 
4.1  Limitations 
Some limitations in our study should be acknowledged. 
Despite this study focusing on a single centre in the Perth 
Metropolitan area, all presentations of STEMI within the 
study time period were included, avoiding selection bias. 
Although the single centre nature may limit generalisability, 
reputable peer-reviewed publications[35,36] and leading epi-
demiological theorists[37] acknowledge cohort studies rely 
on validity or international comparisons to avoid systematic 
error. As such, they do not need to be random sample of a 
large population to provide generalisable knowledge. Inter-
nationally renowned cohort studies, such as the British 
Doctors Study and US Nurses’ Health Study are regarded as 
generalizable knowledge despite their highly selected study 
samples, as external validity of generalisation depends on 
considerations regarding effect modification rather than 
bias/confounding. The study sample included individuals 
from all five tiers of socio-economic status from north met-
ropolitan, south metropolitan and Western Australians 
country health catchment areas. The strength of this study is 
the routine and systematic nature of the collection of data on 
all patents presenting to the centre which reduced both se-
lection and recall bias and the comprehensive inclusion of 
both clinical and administrative data points, allowing for the 
analysis of time to therapy, not typically possible with ad-
ministrative datasets. This study was limited by the lack of 
available data pertaining to why patients presented to a sec-
ondary hospital in the first instance and as such determi-
nants of why patients did not present directly to the PCI-H 
are unknown. 
Further times of ambulance arrival are not recorded 
within the data; and as such FMC-B cannot be measured. 
However, some patients would have self-presented to the 
first non-PCI hospital via private transport. In these in-
stances, the secondary hospital arrival time would in fact be 
their FMC. A brief analysis of linked administrative health 
data using Emergency Department records in Western Aus-
tralia shows 58% of ACS patients arriving at secondary 
hospitals were via private transport. Although this data is 
derived from a different source, it is from the same pool of 
ACS patients in Western Australia and therefore these per-
centages are likely to be generalisable to our sample. Thus, 
if the secondary hospital arrival time is used as proxy for 
FMC, this would be the actual FMC for approximately 58% 
of our patients. The remaining 42% would therefore have 
time-to-treatments that are an under-estimation of the true 
burden of delay. In addition, there are no variables within 
the dataset that outline if the hospital received an ambulance 
ECG transmission; or if the PCI-H was notified of the in-
coming transfer. In lieu of this information, time of ECG, 
CCL activation and PCI-H arrival times were used to calcu-
late pre-hospital ECGs for all patients; and pre-PCI-H acti-
vation of the CCL for transfers. Further limitations included 
the small number of cases in the dataset and some incom-
plete/empty data variables, particularly in time variables. 
The study was unable to follow patients after discharge and 
therefore unable to further assess 30-day and one-year mor-
tality. However, these outcomes were beyond the scope of 
this study, which was concerned with determining the mag-
nitude of delay associated with transfer from hospital type 
rather than its impact on patient outcomes. 
4.2  Conclusions 
Transferred patients’ overall delay times from symp-
tom-onset to balloon inflation is 98% longer than that of 
direct presentations, resulting in significantly longer infarct 
times and potentially poorer outcomes in the long term. This 
study highlights the extent to which the transfer process 
adds to the time to treatment burden and system delay. De-
spite pre-CCL capable hospital activation, PCI-H DTB 
times are not statistically significantly shorter than their 
direct cohort counterparts, representing a missed opportu-
nity in the system to reduce the time delay burden for pa-
tients who required transfer for PCI. Inter-hospital transfers 
will remain an ongoing and unavoidable reality in Western 
Australia’s emergent treatment of ACS due to geographic 
and service provision challenges. The need for efficient 
triage to streamline transfer processes, avoidance of any 
unnecessary transfers by presenting directly to CCL facili-
ties where possible, continuing education for the general 
public about using ambulance services and continued per-
formance of pre-hospital activations are crucial to reduce 
system delay in the treatment of ACS. 
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